Your session is about to expire
← Back to Search
Exercise for Type 2 Diabetes (RESIST Trial)
N/A
Waitlist Available
Led By Lauren M Sparks, PhD
Research Sponsored by Translational Research Institute for Metabolism and Diabetes, Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 30 to 65 years.
Type 2 diabetes determined by self-report or by a fasting glucose > 126mg/dl
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
RESIST Trial Summary
This trial is to help researchers understand why some people don't get the benefits of exercise.
Who is the study for?
This trial is for adults aged 30-65 with Type 2 Diabetes, who are not currently exercising regularly. Participants can be on certain diabetes medications like metformin but must stop them during the study. They should have an HbA1c level that reflects moderate blood sugar control and be willing to exercise daily for the study period.Check my eligibility
What is being tested?
The trial is studying how exercise affects individuals with Type 2 Diabetes. Researchers want to understand why some people don't get the usual benefits from physical activity. Participants will engage in a prescribed exercise routine throughout the study.See study design
What are the potential side effects?
Since this trial involves exercise as an intervention, potential side effects may include muscle soreness, fatigue, or injury related to physical activity. However, these risks are generally low and manageable.
RESIST Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 30 and 65 years old.
Select...
I have type 2 diabetes.
RESIST Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 10 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in ATPmax
Secondary outcome measures
Change in in vivo and in vitro mitochondrial function
Other outcome measures
Promoter methylation
RESIST Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ExerciseExperimental Treatment1 Intervention
10 weeks of aerobic exercise
Group II: Active ControlActive Control1 Intervention
Young athletes as a trained control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~760
Find a Location
Who is running the clinical trial?
Translational Research Institute for Metabolism and Diabetes, FloridaLead Sponsor
40 Previous Clinical Trials
3,513 Total Patients Enrolled
American Diabetes AssociationOTHER
137 Previous Clinical Trials
99,418 Total Patients Enrolled
AdventHealth Translational Research InstituteLead Sponsor
48 Previous Clinical Trials
20,097 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My HbA1c level is between 6.0% and 8.5%, or it's 8.5% or below if I'm on diabetes medication.I am willing to stop my diabetes medication during the study.My latest HbA1c level is between 5.7% and 8.8%, or below 8.9% if I'm on diabetes medication.I am between 30 and 65 years old.I am on diabetes medication, specifically metformin or similar.I have been diagnosed with Type 2 Diabetes.I have type 2 diabetes.I am either male or female.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Exercise
- Group 2: Active Control
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What criteria are necessary for individuals to be eligible participants in this study?
"Eligible candidates for this medical trial must be between 30 and 65 years old and possess a diagnosis of type 2 diabetes mellitus. The team is aiming to recruit 84 participants in total."
Answered by AI
Do individuals over the age of 50 meet the eligibility criteria for this clinical trial?
"This trial requires participants to be aged between 30 and 65 years old. Those below the age of 18 have access to 194 related studies, whereas those over 65 can look into 1,110 different clinical initiatives."
Answered by AI
Are there still opportunities for enrolment in this research project?
"Unfortunately, this clinical trial is not currently enrolling participants; the last update was on November 16th 2022. Nevertheless, 1449 other studies are actively seeking patients at this moment in time."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger